Butylphthalide pretreatment can inhibit the expression of Caspase-3 and increase the level of p-Akt, an Akt phosphorylation product, in the brain of rats with cerebral ischemia–reperfusion injury (Yan, 2013). Here, AKT1 is linked to brain ischemia.